Nemes Rush Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106K Hold
1,155
0.01% 283
2026
Q1
$98.4K Sell
1,155
-10
-0.9% -$891 0.01% 279
2025
Q4
$92.1K Sell
1,165
-1,159
-50% -$90.9K 0.01% 279
2025
Q3
$186K Sell
2,324
-14
-0.6% -$1.19K 0.02% 200
2025
Q2
$213K Hold
2,338
0.02% 193
2025
Q1
$219K Hold
2,338
0.03% 192
2024
Q4
$213K Buy
2,338
+114
+5% +$10.9K 0.03% 182
2024
Q3
$200K Hold
2,224
0.03% 158
2024
Q2
$216K Sell
2,224
-400
-15% -$36.9K 0.03% 151
2024
Q1
$236K Hold
2,624
0.03% 153
2023
Q4
$209K Hold
2,624
0.03% 158
2023
Q3
$187K Sell
2,624
-425
-14% -$31.8K 0.03% 160
2023
Q2
$235K Buy
+3,049
New +$236K 0.04% 153

Other funds holding CL

Nemes Rush Group's CL Position: Q2 2026 in Review

Nemes Rush Group held its Colgate-Palmolive (CL) position steady in Q2 2026 at 1,155 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #283.

Nemes Rush Group first reported a position in CL in Q2 2023 and has held it in 13 quarters since. The position peaked at $236K in Q1 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nemes Rush Group held 1,155 shares of Colgate-Palmolive worth $106K as of Q2 2026.
  • Nemes Rush Group left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Nemes Rush Group's portfolio in Q2 2026, its #283 holding.
  • Nemes Rush Group first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 13 quarters since.
  • Nemes Rush Group's Colgate-Palmolive position peaked at $236K in Q1 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.